Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03812575 · ClinicalTrials.gov registry record
The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Pilot)
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 80
- Enrollment target
NCT03812575 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 80 participants.
The verdict
NCT03812575 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate of the relationships between fractionated exhaled nitric oxide, disease activity, and symptom severity in patients with eosinophilic esophagitis compared to those without eosinophilic esophagitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-01-31 |
| Est. Completion | 2020-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03812575
The ClinicalTrials.gov registry entry for NCT03812575 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03812575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03812575 about?
NCT03812575 is a clinical study titled "The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Pilot)". The purpose of the study is to evaluate of the relationships between fractionated exhaled nitric oxide, disease activity, and symptom severity in patients with eosinophilic esophagitis compared to those without eosinophilic esophagitis.
What is the current status of trial NCT03812575?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2019-01-31. Estimated completion is 2020-06-01.
Who is sponsoring clinical trial NCT03812575?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.